Home Newsfeeds Psychedelic Stock Gainers And Losers From January 1, 2024

Psychedelic Stock Gainers And Losers From January 1, 2024

GAINERS: Cybin (AMEX:CYBN) shares closed up 1.49% at $0.41 LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 5.37%…

byBenzinga Insights

January 1, 2024

1 minute read

GAINERS:

Cybin (AMEX:CYBN) shares closed up 1.49% at $0.41

LOSERS:

ATAI Life Sciences (NASDAQ:ATAI) shares closed down 5.37% at $1.41
Mind Medicine (NASDAQ:MNMD) shares closed down 5.26% at $3.60
Compass Pathways (NASDAQ:CMPS) shares closed down 2.98% at $8.80
GH Research (NASDAQ:GHRS) shares closed down 1.62% at $5.45

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

NewLake Capital Partners Q4 Revenue Grows 35.7% YoY, Here Are The Details

By Vuk Zdinjak

March 9, 10:10 AM

NewLake Capital Partners, Inc. (OCTQX:NLCP) revenue in 2022 was $44.8 million, as compared to $28.1 million, an increase of 59.6% year-over-year. Q4 2022 Financial Highlights

NLCP

Surging Uranium Demand, Supply Constraints Fuel Predictions Of Record Price Increases

By Stjepan Kalinic

January 29, 6:58 PM

Uranium prices hit new highs as demand grows and supply struggles to meet it, with analysts predicting a surge to $160/lb this year and a potential squeeze in the market. C

CCJ

Why NewAge Shares Are Getting Hammered

By Henry Khederian

September 7, 2:13 PM

Newage Inc (NASDAQ: NBEV) shares are trading lower by 22.56% to $0.09 on continued weakness after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code. What Else?

NBEV